TrialJournal of hematology & oncology2016

Serial cfDNA assessment of response and resistance to EGFR-TKI for patients with EGFR-L858R mutant lung cancer from a prospective clinical trial.

Qing Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.